Skip to content

Dr. Gearóid Tuohy

AGTC and Bionic Sight announce a strategic collaboration to use optogenetics and neuroprosthetics, together with specific software, to improve visual perception

AGTC Inc (NASDAQ: AGTC) based in Gainesville, Florida and Bionic Sight LLC, based in New York, have announced a strategic collaboration to develop opogenetic therapies… Read More »AGTC and Bionic Sight announce a strategic collaboration to use optogenetics and neuroprosthetics, together with specific software, to improve visual perception

5-year progression from unilateral to bilateral AMD, and associated risk factors, highlighted in three continent AMD consortium research

Researchers based at the Centre for Vision Research, Westmead Institute, University of Sydney, have reported their findings using three population-based cohorts to show the proportion… Read More »5-year progression from unilateral to bilateral AMD, and associated risk factors, highlighted in three continent AMD consortium research

GenSight, a French biotechnology company, has announced the receipt of FDA orphan designation for retinitis pigmentosa gene therapy treatment in the US.

GenSight Biologics S.A. (Euronext: SIGHT) has announced the receipt of FDA Orphan Drug Designation in the US for its experimental retinitis pigmentosa (RP) treatment, “GS030”.… Read More »GenSight, a French biotechnology company, has announced the receipt of FDA orphan designation for retinitis pigmentosa gene therapy treatment in the US.